candesartan cilexetil has been researched along with Amentia in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansson, L | 1 |
| Lithell, H | 1 |
| Skoog, I | 1 |
| Baro, F | 1 |
| Bánki, CM | 1 |
| Breteler, M | 1 |
| Castaigne, A | 1 |
| Correia, M | 1 |
| Degaute, JP | 1 |
| Elmfeldt, D | 1 |
| Engedal, K | 1 |
| Farsang, C | 1 |
| Ferro, J | 1 |
| Hachinski, V | 1 |
| Hofman, A | 1 |
| James, OF | 1 |
| Krisin, E | 1 |
| Leeman, M | 1 |
| de Leeuw, PW | 1 |
| Leys, D | 1 |
| Lobo, A | 1 |
| Nordby, G | 1 |
| Olofsson, B | 1 |
| Opolski, G | 1 |
| Prince, M | 1 |
| Reischies, FM | 1 |
1 trial available for candesartan cilexetil and Amentia
| Article | Year |
|---|---|
Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.
Topics: Aged; Aged, 80 and over; Aging; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimida | 2000 |